The share of Brazilian pharmacy publications among the world's top 10% most-cited is forecasted to decrease significantly from 2.36% in 2024 to 0.044% in 2028. This suggests a declining trend over the upcoming years. In 2023, this share stood at 2.89%, showcasing a consistent downward trajectory. The year-on-year variation highlights this drop in prominence, with substantial declines projected annually. The compound annual growth rate (CAGR) over the upcoming five-year period underscores a concerning decrease in Brazil's share of highly cited pharmacy publications.
Future trends to watch for include policy changes that might impact research output quality and funding availability, as well as potential collaborations with international research entities that could reverse or mitigate this decline.
